Ver mas grande
BARD1 antibody
FT-FNab00803
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB |
| Target | BARD1 |
| Research Area | Epigenetics, Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:1000 |
| Type Clonality | polyclonal |
| Immunogen | BRCA1 associated RING domain 1 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | BRCA1-associated RING domain protein 1 (BARD-1)|RING-type E3 ubiquitin transferase BARD1|BARD1 |
| Host | Rabbit |
| UniProt ID | Q99728 |
| Gene ID | 580 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human |
| Observed MW | 90-100 kDa |
| Background | Probable E3 ubiquitin-protein ligase. The BRCA1-BARD1 heterodimer specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional |
Más información
BARD1 antibody